ENDRA Life Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ENDRA Life Sciences Inc. on August 17, 2018, regarding an event reported on August 16, 2018. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Ann Arbor, Michigan.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report references the Company's Form 10-Q for the period ended June 30, 2018, which indicated that stockholders' equity fell below the minimum requirement of $2,500,000 for continued listing on The Nasdaq Capital Market.
Material Changes and Listing Status
On August 16, 2018, the Company received a notification from The Nasdaq Stock Market LLC stating it no longer met Listing Rule 5550(b)(1) due to insufficient stockholders' equity. The notification has no immediate effect on the listing status. The Company has 45 calendar days (until October 1, 2018) to submit a plan to regain compliance. If the plan is accepted, an extension of up to 180 days may be granted to demonstrate compliance. Failure to regain compliance could result in delisting.
Outlook, Risks, and Management Commentary
Management is currently evaluating options to regain compliance and intends to submit a plan by the deadline. The Company explicitly states there can be no assurance that it will successfully regain compliance with the minimum stockholders' equity requirement or maintain compliance with other continued listing requirements. Risks include potential delisting if the compliance plan is rejected or if compliance is not achieved within the allowed timeframe.
Key Facts for Investor Verification
- Verify the exact stockholders' equity figure reported in the Form 10-Q for the period ended June 30, 2018.
- Monitor the submission of the Company's compliance plan to Nasdaq by October 1, 2018.
- Track any subsequent announcements regarding the acceptance of the compliance plan or potential delisting notices.
- Review the Company's capital raising activities or strategic actions intended to restore equity levels.